急性心肌梗死合并心源性休克的临床结局:Gulf-Cardiogenic Shock登记研究
该研究基于Gulf-Cardiogenic Shock登记研究,纳入2020年1月至2022年12月间1513例急性心肌梗死合并心源性休克患者,旨在分析院内及短期随访死亡率。结果显示,急性心肌梗死合并心源性休克的发生率为4.1%(1513/37379),中位年龄60岁,ST段抬高型心肌梗死占73.83%,68.94%的患者处于SCAI分期D期和E期。院内死亡率为45.5%,与院内死亡相关的因素包括既往冠状动脉旁路移植术、脑血管意外、慢性肾脏病、非ST段抬高型心肌梗死、心脏骤停、SCAI分期D和E期、QRS波延长、右心室功能障碍及室间隔破裂。40%的患者接受了有创血流动力学监测,90.02%接受了血运重建,45.80%接受了机械循环支持(其中41.31%使用主动脉内球囊反搏,14.21%使用体外膜肺氧合/Impella装置)。12个月生存率为51.49%(95%CI 46.44%-56.29%)。
要点
- 急性心肌梗死合并心源性休克患者院内死亡率为45.5%,12个月生存率为51.49%(95%CI 46.44%-56.29%)。
- SCAI分期D和E期与院内死亡强相关(OR 19.146;95%CI 9.902-37.017),68.94%的患者处于该分期。
- 心脏骤停(OR 5.702;95%CI 3.640-8.933)和室间隔破裂(OR 6.008;95%CI 2.256-15.998)是院内死亡的重要危险因素。
- 90.02%的患者接受了血运重建,45.80%接受了机械循环支持(41.31%使用主动脉内球囊反搏,14.21%使用体外膜肺氧合/Impella装置)。
- 既往冠状动脉旁路移植术(OR 2.49;95%CI 1.321-4.693)、脑血管意外(OR 1.621;95%CI 1.032-2.547)、慢性肾脏病(OR 1.572;95%CI 1.158-2.136)、非ST段抬高型心肌梗死(OR 1.744;95%CI 1.058-2.873)、QRS波延长(OR 10.012;95%CI 1.006-1.019)及右心室功能障碍(OR 1.679;
适用人群与场景
- 2020年1月至2022年12月间Gulf-Cardiogenic Shock登记研究中诊断为急性心肌梗死合并心源性休克的1513例患者。
研究设计与关键结果
- 研究类型:Gulf-Cardiogenic Shock登记研究,纳入1513例急性心肌梗死合并心源性休克患者。
- 急性心肌梗死合并心源性休克的发生率为4.1%(1513/37379),中位年龄60岁,ST段抬高型心肌梗死占73.83%。
- 院内死亡率为45.5%,68.94%的患者处于SCAI分期D期和E期。
- 与院内死亡相关的因素:既往冠状动脉旁路移植术(OR 2.49;95%CI 1.321-4.693)、脑血管意外(OR 1.621;95%CI 1.032-2.547)、慢性肾脏病(OR 1.572;95%CI 1.158-2.136)、非ST段抬高型心肌梗死(OR 1.744;95%CI 1.058-2.873)、心脏骤停(OR 5.702;95%CI 3.640-8.933)、SCAI分期D和E期(OR 19.146;95%CI 9.902-37.017)、QRS波延长(OR 10.012;95%CI 1.006-1.019)、右心室功能障碍(OR 1.679;95%CI 1.267-2.226)、室间隔破裂(OR 6.008;95%CI 2.256-15.998)。
- 40%的患者接受了有创血流动力学监测,90.02%接受了血运重建,45.80%接受了机械循环支持(41.31%使用主动脉内球囊反搏,14.21%使用体外膜肺氧合/Impella装置)。
- 12个月生存率为51.49%(95%CI 46.44%-56.29%)。
证据类型、等级与局限
- 证据类型:登记研究(Gulf-Cardiogenic Shock registry)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究提示,急性心肌梗死合并心源性休克患者院内死亡率高(45.5%),SCAI分期D和E期、心脏骤停、室间隔破裂等因素与院内死亡相关。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: There is a paucity of data regarding acute myocardial infarction (MI) complicated by cardiogenic shock (AMI-CS) in the Gulf region. This study addressed this knowledge gap by examining patients experiencing AMI-CS in the Gulf region and analyzing hospital and short-term follow-up mortality. Methods: The Gulf-Cardiogenic Shock registry included 1,513 patients with AMI-CS diagnosed between January 2020 and December 2022. Results: The incidence of AMI-CS was 4.1% (1,513/37,379). The median age was 60 years. The most common presentation was ST-elevation MI (73.83%). In-hospital mortality was 45.5%. Majority of patients were in SCAI (Society for Cardiovascular Angiography and Interventions shock classification) stage D and E (68.94%). Factors associated with hospital mortality were previous coronary artery bypass graft (odds ratio [OR]: 2.49; 95% confidence interval [CI]: 1.321-4.693), cerebrovascular accident (OR: 1.621; 95% CI: 1.032-2.547), chronic kidney disease (OR: 1.572; 95% CI: 1.158-2.136), non-ST-elevation MI (OR: 1.744; 95% CI: 1.058-2.873), cardiac arrest (OR: 5.702; 95% CI: 3.640-8.933), SCAI stage D and E (OR: 19.146; 95% CI: 9.902-37.017), prolonged QRS (OR: 10.012; 95% CI: 1.006-1.019), right ventricular dysfunction (OR: 1.679; 95% CI: 1.267-2.226), and ventricular septal rupture (OR: 6.008; 95% CI: 2.256-15.998). Forty percent had invasive hemodynamic monitoring, 90.02% underwent revascularization, and 45.80% received mechanical circulatory support (41.31% had intra-aortic balloon pump and 14.21% had extracorporeal membrane oxygenation/Impella devices). Survival at 12 months was 51.49% (95% CI: 46.44%-56.29%). Conclusions: The study highlighted the significant burden of AMI-CS in this region, with high in-hospital mortality. The study identified several key risk factors associated with increased hospital mortality. Despite the utilization of invasive hemodynamic monitoring, revascularization, and mechanical circulatory support in a substantial proportion of patients, the 12-month survival rate remained relatively low.
参考来源
- Daoulah A, Alshehri M, Panduranga P, et al. CLINICAL OUTCOMES OF PATIENTS WITH CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION: THE GULF-CARDIOGENIC SHOCK REGISTRY. Shock. 2024. PMID: 39158570. doi:10.1097/SHK.0000000000002433
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。